Granulomatous myositis induced by anti-PD-1 monoclonal antibodies

被引：14
|
作者：
Uchio, Naohiro [1 ]
Taira, Kenichiro [1 ]
Ikenaga, Chiseko [1 ]
Unuma, Atsushi [1 ]
Kadoya, Masato [2 ]
Kubota, Akatsuki [1 ]
Toda, Tatsushi [1 ]
Shimizu, Jun [1 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo, Japan
[2] Natl Def Med Coll, Dept Neurol & Antiaging Med, Saitama, Japan
来源：
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION | 2018年 / 5卷 / 04期
基金：
日本学术振兴会;
关键词：
D O I：
10.1212/NXI.0000000000000464
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies
    Imamura, K.
    Sato, R.
    Sakata, S.
    Ikeda, T.
    Horio, Y.
    Iyama, S.
    Akaike, K.
    Hamada, S.
    Jodai, T.
    Nakashima, K.
    Ishizuka, S.
    Sato, N.
    Saruwatari, K.
    Saeki, S.
    Tomita, Y.
    Ichiyasu, H.
    Sakagami, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [22] Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies
    Sato, Ryo
    Imamura, Kosuke
    Sakata, Shinya
    Ikeda, Tokunori
    Horio, Yuko
    Iyama, Shinji
    Akaike, Kimitaka
    Hamada, Shohei
    Jodai, Takayuki
    Nakashima, Kei
    Ishizuka, Shiho
    Sato, Nahoko
    Saruwatari, Koichi
    Saeki, Sho
    Tomita, Yusuke
    Sakagami, Takuro
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (06)
  • [23] Pulmonary sarcoidosis induced by the anti-PD-1 monoclonal antibody pembrolizumab or post-immunotherapy granulomatous reaction: which is more appropriate terminology?
    Paydas, S.
    ANNALS OF ONCOLOGY, 2016, 27 (08) : 1650 - 1651
  • [24] Longitudinal analysis of the landscape of cancer trials testing anti-PD-1/L1 monoclonal antibodies
    Tang, Jun
    Pearce, Laura
    O'Donnell-Tormey, Jill
    Hubbard-Lucey, Vanessa M.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [25] Dying cells expose a nuclear antigen cross-reacting with anti-PD-1 monoclonal antibodies
    Metzger, Philipp
    Kirchleitner, Sabrina V.
    Koenig, Lars M.
    Hoerth, Christine
    Kobold, Sebastian
    Endres, Stefan
    Schnurr, Max
    Duewell, Peter
    SCIENTIFIC REPORTS, 2018, 8
  • [26] Dying cells expose a nuclear antigen cross-reacting with anti-PD-1 monoclonal antibodies
    Philipp Metzger
    Sabrina V. Kirchleitner
    Lars M. Koenig
    Christine Hörth
    Sebastian Kobold
    Stefan Endres
    Max Schnurr
    Peter Duewell
    Scientific Reports, 8
  • [27] Second primary melanoma in advanced melanoma patients treated with anti-PD-1 monoclonal antibodies.
    Funck-Brentano, Elisa
    Charvet, Estelle
    Chaplain, Louise
    Gantzer, Amelie
    Kassem, Oula
    Longvert, Christine
    Blom, Astrid
    Dupin, Nicolas
    Aractingi, Selim
    Hamon, Maxime
    Zimmermann, Ute
    Emile, Jean-Francois
    Sohier, Pierre
    Kramkimel, Nora
    Saiag, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Granulomatous and lichenoid dermatitis after IgG4 anti-PD-1 monoclonal antibody therapy for advanced cancer
    Diaz-Perez, Julio A.
    Beveridge, Mara G.
    Victor, Thomas A.
    Cibull, Thomas L.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2018, 45 (06) : 434 - 438
  • [29] Colitis induced by immune checkpoint inhibitors: Anti-CTLA-4 antibodies and anti-PD-1/PDL-1 antibodies
    Vozy, A.
    Coutzac, C.
    ONCOLOGIE, 2016, 18 (9-10) : 501 - 508
  • [30] Anti-PD-1 antibodies therapeutic use in lymphoid neoplasms
    Bounaix, Laura
    Bendouda, Mohammed
    Bay, Jacques-Olivier
    Lemal, Richard
    BULLETIN DU CANCER, 2016, 103 : S160 - S163
12345